Premium
Leukemia‐associated antigenic isoforms induce a specific immune response in children with T‐ALL
Author(s) -
Dohnal Alexander Michael,
Inthal Andrea,
Felzmann Thomas,
Glatt Sebastian,
Sommergruber Wolfgang,
Mann Georg,
Gadner Helmut,
PanzerGrümayer E. Renate
Publication year - 2006
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/ijc.22224
Subject(s) - antigen , immunogenicity , immune system , biology , immunology , leukemia , t cell , immunotherapy , antibody , microbiology and biotechnology
The potential immunogenicity of acute lymphoblastic leukemia of the T cell (T‐ALL), a small subgroup of childhood leukemia with increased risk for treatment failure and early relapse, was addressed by serological identification of leukemia‐derived antigens by recombinant expression cloning (SEREX). Thirteen antigens with homology to known genes that are involved in critical cellular processes were detected. Further characterization of the 4 novel isoforms revealed that 3 (HECTD1Δ, CX‐ORF‐15Δ and hCAP‐EΔ) had restricted mRNA expression in more than 70% of T‐ALLs ( n = 22) and that specific antibodies against these isoforms were detected in up to 30% of patients ( n = 16), with the highest frequency for HECTD1Δ. The latter protein was present at high abundance in T‐ALLs but not in normal hematopoietic tissues. Given that the leukemia‐associated antigens detected in this study have an intracellular localization, the generation of immune effector responses most likely requires antigen presentation. To test this assumption, dendritic cells were loaded with HECTD1Δ protein and used for T cell stimulation. A specific T cell response was induced in vitro in all 3 healthy donors studied, including a former T‐ALL patient. These data suggest that T‐ALL may induce a specific cellular and humoral antileukemia immune response in children, thereby supporting new approaches for immunotherapy. © 2006 Wiley‐Liss, Inc.